Aleigha R Lawless

5PUBLICATIONS

80CO-AUTHORS

Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 24, 2026

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Dec 12, 2025

Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Dec 04, 2025

Real-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations.

Derek Effiom, Tyler Aprati, Anastasios Karneris

|Sep 26, 2025

Design of a potent interleukin-21 mimic for cancer immunotherapy.

Jung-Ho Chun, Birkley S Lim, Suyasha Roy

|Jan 09, 2025

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.

Yi Sun, Luke Maggs, Apekshya Panda

Pageof 1

Frequent Collaborators

Genevieve M Boland

Russell W Jenkins

Ryan Sullivan

Arnav Mehta

Keith T Flaherty

Moshe Sade-Feldman

Tatyana Sharova

Or-Yam Revach

Luke Maggs

Angelina M Cicerchia

Frequent Collaborators

Genevieve M Boland

Russell W Jenkins

Ryan Sullivan

Arnav Mehta